Ekso Bionics (NASDAQ:EKSO) Now Covered by StockNews.com

Stock analysts at StockNews.com started coverage on shares of Ekso Bionics (NASDAQ:EKSOGet Rating) in a note issued to investors on Monday. The firm set a “sell” rating on the stock.

Separately, HC Wainwright decreased their price target on shares of Ekso Bionics from $11.00 to $9.00 and set a “buy” rating on the stock in a research note on Friday, July 29th.

Ekso Bionics Trading Down 0.3 %

NASDAQ:EKSO opened at $1.30 on Monday. The company’s 50-day moving average price is $1.58 and its 200-day moving average price is $1.81. The company has a market cap of $17.08 million, a P/E ratio of -1.13 and a beta of 1.85. Ekso Bionics has a twelve month low of $1.26 and a twelve month high of $3.55.

Hedge Funds Weigh In On Ekso Bionics

A number of institutional investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP purchased a new stake in shares of Ekso Bionics in the 3rd quarter valued at approximately $28,000. Renaissance Technologies LLC grew its holdings in shares of Ekso Bionics by 153.4% in the second quarter. Renaissance Technologies LLC now owns 44,606 shares of the company’s stock valued at $74,000 after purchasing an additional 27,006 shares in the last quarter. Finally, Essex Investment Management Co. LLC grew its holdings in shares of Ekso Bionics by 90.7% in the third quarter. Essex Investment Management Co. LLC now owns 319,673 shares of the company’s stock valued at $499,000 after purchasing an additional 152,028 shares in the last quarter. 12.47% of the stock is owned by hedge funds and other institutional investors.

Ekso Bionics Company Profile

(Get Rating)

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.

Read More

Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.